A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Inclusion Criteria-Crohn's Disease: - Diagnosis of Crohn's Disease (CD), as confirmed by endoscopy and histopathology - Moderately to severely active CD as defined by Clinical Disease Activity Index (CDAI) and Simple Endoscopic Score (SES-CD) - Meets drug stabilization requirements Inclusion Criteria-Ulcerative Colitis: - Diagnosis of Ulcerative Colitis (UC), as confirmed by endoscopy and histopathology - Moderately to severely active UC as defined by a 3-component MMCS - Meets drug stabilization requirements Exclusion Criteria-Crohn's Disease: - Diagnosis of indeterminate colitis - Suspected or diagnosed intra-abdominal or perianal abscess at Screening - Previous small bowel resection with combined resected length of \> 100 cm or previous colonic resection of \> 2 segments - CD isolated to the stomach, duodenum, jejunum, or perianal region, without colonic and/or ileal involvement Exclusion Criteria-Ulcerative Colitis: - Current evidence or within recent history (within last 6 months) of fulminant colitis, toxic megacolon, or bowel perforation - Current stoma or impending need for colostomy or ileostomy - Received IV corticosteroids within 14 days prior to Screening or during the Screening Phase - Previous total proctocolectomy or subtotal colectomy Always talk to your doctor about whether this trial is right for you.